Clinical Outcomes of Moderately Hypofractionated Concurrent Chemoradiotherapy for Newly Diagnosed Glioblastoma
Sign Up to like & getrecommendations! Published in 2023 at "Yonsei Medical Journal"
DOI: 10.3349/ymj.2022.0352
Abstract: Purpose Hypofractionated radiotherapy (HypoRT) has recently been implemented in patients with glioblastoma (GBM) receiving concurrent temozolomide. Lymphopenia during treatment (LDT) is considered an important prognostic factor of clinical outcomes for GBM. We aimed to investigate… read more here.
Keywords: moderately hypofractionated; clinical outcomes; outcomes moderately; hypofractionated concurrent ... See more keywords
Journey to hypofractionation in radiotherapy for breast cancer: critical reviews for recent updates
Sign Up to like & getrecommendations! Published in 2022 at "Radiation Oncology Journal"
DOI: 10.3857/roj.2022.00577
Abstract: Historical conventional fractionated radiation therapy (RT) for breast cancer consisted of 1.8–2.0 Gy per fraction with a total dose of 45–60 Gy over 5–7 weeks. Based on radiobiological characteristics, a low α/β is suspected of… read more here.
Keywords: hyport; breast cancer; journey hypofractionation; oncology ... See more keywords